Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized trial compared two dosing regimens of an antifungal drug for invasive candidiasis; the study is completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Antifungal drug (study 0991-801)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Invasive Candidiasis | Phase 3 | Status: COMPLETED | Results posted: 2009-03-24